300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Fitness
Marketplace
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Theatre
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Iran
Isle of Man
Guinea
Nepal
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Turkey
Uruguay
Uganda
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
El Salvador
Rwanda
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Bangladesh
Belgium
Barbados
Angola
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Europe
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Cyprus
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Qatar
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
KISCO, VC Fund

KISCO

VC Fund

Osaka, Japan

KISCO is a VC fund in Osaka focused on Health Care and Medical. KISCO engages in the sales of synthetic resins, chemicals, electronics materials, and packaging materials. KISCO offers domestic demand import and export services. KISCO Corporation was founded in 1921 and is based in Osaka, Japan.

Total investments:
5
Last investment:
Lead investor:
0%

Last updated:

Industries KISCO invests in

Health CareMedicalNursing and Residential CareRoboticsNutrition

Stages KISCO invests in

Series ASeedSeries B

Countries KISCO invests in

Japan

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Investment Focus

Industry

  • Health Care 3 (60%)
  • Medical 2 (40%)
  • Nursing and Residential Care 2 (40%)
  • Robotics 1 (20%)
  • Nutrition 1 (20%)
See all 11 industries →

Stage

  • Series A 2 (40%)
  • Seed 1 (20%)
  • Series B 1 (20%)

Team

NameTitleInvestmentsLinksEmail
Koichi Kishimoto President and CEO
President and CEO Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
Gaudi Clinical Gaudi Clinical
Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments. $8.9M / Series A / Feb 07, 2025
Gaudi Clinical Gaudi Clinical
Gaudi Clinical is a health care firm that engages in regenerative medicine outsourcing and cell processing contract establishments. $8.9M / Series A / Feb 07, 2025
United Immunity United Immunity
United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy. $4.5M / Series B / Sep 07, 2021
EditForce EditForce
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies. $24.8M / Seed / Feb 03, 2016
Seven Dreamers Laboratories Seven Dreamers Laboratories
Seven Dreamers Laboratories is the maker of personal-use devices dedicated to creating totally novel, world-first products. The company develops carbon tool, medical equipment with haute couture design, and a household laundry robot. It targets to commercialize the Laundroid, a laundry-folding robot that uses image-recognition algorithms and techto identify types of clothing, such as t-shirts, towels, and pants, fold each one appropriately, and sort them by item or family member.The company was founded in 2011 and is based in Tokyo, Japan. $212.6M / Series A / Jun 08, 2015

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Retail
Oil and Gas
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Fitness
Marketplace
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Theatre
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Iran
Isle of Man
Guinea
Nepal
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Turkey
Uruguay
Uganda
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
Ghana
United Kingdom
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
El Salvador
Rwanda
Senegal
Tanzania
Germany
India
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Bangladesh
Belgium
Barbados
Angola
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Europe
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Cyprus
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Qatar
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Slovenia
Mongolia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does KISCO invest in?

KISCO invests primarily in Health Care, Medical and Nursing and Residential Care startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact KISCO?

Public channels for KISCO include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at KISCO?

The team at KISCO includes Koichi Kishimoto (President and CEO). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
KISCO KISCO Find emails